PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $811,391 | -21.7% | 78,244 | +8.1% | 0.00% | – |
Q2 2023 | $1,036,511 | +54.9% | 72,382 | -22.7% | 0.00% | – |
Q1 2023 | $669,003 | -13.8% | 93,698 | +35.4% | 0.00% | – |
Q4 2022 | $776,290 | -24.3% | 69,188 | -25.1% | 0.00% | – |
Q3 2022 | $1,025,000 | +11.5% | 92,430 | -15.1% | 0.00% | – |
Q2 2022 | $919,000 | -20.2% | 108,862 | +28.7% | 0.00% | – |
Q1 2022 | $1,151,000 | -58.0% | 84,600 | -39.2% | 0.00% | – |
Q4 2021 | $2,738,000 | +219.5% | 139,168 | +420.6% | 0.00% | – |
Q3 2021 | $857,000 | -4.4% | 26,733 | +0.9% | 0.00% | – |
Q2 2021 | $896,000 | +44700.0% | 26,492 | +44801.7% | 0.00% | – |
Q1 2021 | $2,000 | -99.2% | 59 | -99.3% | 0.00% | – |
Q4 2020 | $264,000 | +560.0% | 7,933 | +624.5% | 0.00% | – |
Q3 2020 | $40,000 | -63.6% | 1,095 | -67.1% | 0.00% | – |
Q2 2020 | $110,000 | +423.8% | 3,332 | +300.5% | 0.00% | – |
Q1 2020 | $21,000 | -95.3% | 832 | -94.2% | 0.00% | – |
Q4 2019 | $450,000 | – | 14,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |